ABIOMED Liabilities 2024

ABIOMED Aktienanalyse

What does ABIOMED do?

Abiomed Inc. is one of the most innovative companies in the medical technology industry. It was founded in 1981 and is headquartered in Danvers, Massachusetts. The company specializes in the development, manufacturing, and marketing of medical devices aimed at saving or improving patients' lives. Abiomed started as a small company focused on implantation technology for cardiac arrhythmias. However, the company soon recognized the need to concentrate on providing solutions for cardiac intensive care. Today, Abiomed is a leader in the field of cardiopulmonary support systems and offers innovative devices to support the heart. Abiomed's business model revolves around leveraging its expertise in medical technology for cardiology interventions and intensive care and bringing innovative products to market. The company has industry experts and doctors on its team who contribute to the development and manufacturing of products. This highest level of professionalism is also reflected in the distribution channels Abiomed utilizes, with a focus on delivering its products to clinics specialized in critical medical interventions. Abiomed is divided into various business segments that concentrate on the medical devices the company offers. One of these segments is the Impella portfolio, which focuses on heart pumps for acute heart failure. These pumps are capable of supporting the heart during cardiological intervention by pumping blood into the heart while artificially ventilating it. The Impella portfolio is recognized as a standard in cardiac intensive care. Another important area for Abiomed is product development. The company heavily invests in researching and developing new products to meet the current demand in cardiology on the market. Abiomed is aware that rapid development of new products can provide a competitive advantage and, therefore, is an essential part of its business model. The technology offered by Abiomed is revolutionary and allows for the treatment of patients with acute heart failure, which was previously difficult or impossible. This is a significant milestone for the company and the healthcare industry in general. Abiomed is aware of its responsibility towards patients, doctors, and hospitals and is continuously working to develop innovative solutions for the healthcare industry. In summary, Abiomed Inc. is a leading company in the medical technology industry that focuses on cardiology intervention and intensive care. The company is innovative and offers products that can save and improve patients' lives. The Impella portfolio, specializing in acute heart failure, is an important part of its business model. Abiomed heavily invests in research and development to consistently provide innovative solutions to its customers. ABIOMED ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Liabilities Details

Assessing ABIOMED's Liabilities

ABIOMED's liabilities constitute the company's financial obligations and debts owed to external parties and stakeholders. They are categorized into current liabilities, due within a year, and long-term liabilities, which are due over a longer period. A detailed assessment of these liabilities is crucial for evaluating ABIOMED's financial stability, operational efficiency, and long-term viability.

Year-to-Year Comparison

By comparing ABIOMED's liabilities year-over-year, investors can identify trends, shifts, and anomalies in the company’s financial positioning. A decrease in total liabilities often signals financial strengthening, while an increase might indicate enhanced investments, acquisitions, or potential financial strain.

Impact on Investments

ABIOMED's total liabilities play a significant role in determining the company's leverage and risk profile. Investors and analysts examine this aspect meticulously to ascertain the firm’s ability to meet its financial obligations, which influences investment attractiveness and credit ratings.

Interpreting Liability Fluctuations

Shifts in ABIOMED’s liability structure indicate changes in its financial management and strategy. A reduction in liabilities reflects efficient financial management or debt payoffs, while an increase may suggest expansion, acquisition activities, or accruing operational expenses, each carrying distinct implications for investors.

Frequently Asked Questions about ABIOMED Stock

What is the level of liabilities of ABIOMED this year?

ABIOMED has a debt balance of 170.07 M USD this year.

What were the liabilities of ABIOMED compared to the previous year?

The liabilities of ABIOMED have increased by 3.26% increased compared to the previous year.

What are the consequences of high debt for investors of ABIOMED?

High liabilities can pose a risk for investors of ABIOMED, as they can weaken the company's financial position and impair its ability to meet its obligations.

What consequences do low liabilities have for investors in ABIOMED?

Low liabilities mean that ABIOMED has a strong financial position and is able to meet its obligations without overburdening its finances.

How does an increase in liabilities of ABIOMED affect the company?

An increase in liabilities of ABIOMED can lead to the company having more obligations and potentially find it more difficult to meet its financial commitments.

How does a reduction in the liabilities of ABIOMED affect the company?

A decrease in the liabilities of ABIOMED can lead to the company having fewer obligations and a stronger financial position, which can make it easier for the company to fulfill its financial commitments.

What are some factors that influence the liabilities of ABIOMED?

Some factors that can influence the liabilities of ABIOMED include investments, acquisitions, operating costs, and sales development.

Why is the level of liabilities of ABIOMED so important for investors?

The liabilities of ABIOMED are important for investors as they serve as an indicator of the company's financial stability and provide investors with information on how the company meets its financial obligations.

What strategic measures can ABIOMED take to modify the liabilities?

To change its liabilities, ABIOMED can take measures such as cost savings, increasing revenue, selling assets, raising investments, or forming partnerships. It is important for the company to conduct a thorough review of its financial situation to choose the best strategic actions.

How much dividend does ABIOMED pay?

Over the past 12 months, ABIOMED paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, ABIOMED is expected to pay a dividend of 0 USD.

What is the dividend yield of ABIOMED?

The current dividend yield of ABIOMED is .

When does ABIOMED pay dividends?

ABIOMED pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of ABIOMED?

ABIOMED paid dividends every year for the past 0 years.

What is the dividend of ABIOMED?

For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.

In which sector is ABIOMED located?

ABIOMED is assigned to the 'Health' sector.

Wann musste ich die Aktien von ABIOMED kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of ABIOMED from 5/6/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 5/6/2024.

When did ABIOMED pay the last dividend?

The last dividend was paid out on 5/6/2024.

What was the dividend of ABIOMED in the year 2023?

In the year 2023, ABIOMED distributed 0 USD as dividends.

In which currency does ABIOMED pay out the dividend?

The dividends of ABIOMED are distributed in USD.